| Features: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Taurine (2-aminoethanesulfonic acid) is a sulfur-containing “amino acid–like” molecule (not incorporated into proteins). It’s abundant in many tissues and is best thought of as a homeostatic modulator rather than a direct cytotoxin.Core biology themes: -Osmoregulation / membrane stabilization -Mitochondrial support + anti-oxidant tone (indirect) -Calcium handling modulation -Anti-inflammatory signaling (context-dependent) -Bile acid conjugation (tauroursodeoxycholic-type physiology, but taurine itself is a conjugating substrate) Cancer relevance (preclinical/adjunct framing): -Often discussed as protective (normal-tissue protection) and stress-modulating, not a primary anti-cancer agent. -May influence redox balance, ER stress, and inflammation, which can indirectly affect tumor biology or therapy tolerance (model-dependent). -ROS axis: tends to reduce oxidative injury (indirect) -NRF2: sometimes reported as part of antioxidant adaptation, but not a “core direct target”Amino acid that benefits the heart, brain and immune system. Taurine, an organic compound containing sulfur in its chemical structure, possesses anti-inflammatory, anti-oxidant, and various physiological functions within the cardiovascular, kidney, endocrine, and immune systems. Also an LDH inhibitor -Neuroprotection: helps protect neurons against excitotoxicity (e.g., glutamate damage) and ROS stress. -Anti-oxidative action: scavenges ROS, reducing oxidative stress seen in AD brains. -Anti-inflammatory -Calcium homeostasis Helps maintain intracellular calcium balance, disrupted in AD. -Amyloid-beta toxicity May reduce Aβ-induced neurotoxicity and cell death in vitro. -Tau pathology: possible reduction of tau hyperphosphorylation. -Memory and cognition may improve learning and memory.
Time-Scale Flag (TSF): P / R / G
Alzheimer’s Disease (AD)-Oriented Time-Scale Flagged Pathway Table
Time-Scale Flag (TSF): P / R / G
|
| Source: |
| Type: |
| Cytochrome c ** The term "release of cytochrome c" ** an increase in level for the cytosol. Small hemeprotein found loosely associated with the inner membrane of the mitochondrion where it plays a critical role in cellular respiration. Cytochrome c is highly water-soluble, unlike other cytochromes. It is capable of undergoing oxidation and reduction as its iron atom converts between the ferrous and ferric forms, but does not bind oxygen. It also plays a major role in cell apoptosis. The term "release of cytochrome c" refers to a critical step in the process of programmed cell death, also known as apoptosis. In its new location—the cytosol—cytochrome c participates in the apoptotic signaling pathway by helping to form the apoptosome, which activates caspases that execute cell death. Cytochrome c is a small protein normally located in the mitochondrial intermembrane space. Its primary role in healthy cells is to participate in the electron transport chain, a process that helps produce energy (ATP) through oxidative phosphorylation. Mitochondrial outer membrane permeability leads to the release of cytochrome c from the mitochondria into the cytosol. The release of cytochrome c is a pivotal event in apoptosis where cytochrome c moves from the mitochondria to the cytosol, initiating a chain reaction that leads to programmed cell death. On the one hand, cytochrome c can promote cancer cell survival and proliferation by regulating the activity of various signaling pathways, such as the PI3K/AKT pathway. This can lead to increased cell growth and resistance to apoptosis, which are hallmarks of cancer. On the other hand, cytochrome c can also induce apoptosis in cancer cells by interacting with other proteins, such as Apaf-1 and caspase-9. This can lead to the activation of the intrinsic apoptotic pathway, which can result in the death of cancer cells. Overexpressed in Breast, Lung, Colon, and Prostrate. Underexpressed in Ovarian, and Pancreatic. |
| 3950- | Taur, | Taurine Supplementation as a Neuroprotective Strategy upon Brain Dysfunction in Metabolic Syndrome and Diabetes |
| - | Review, | Diabetic, | NA | - | Review, | Stroke, | NA | - | Review, | AD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:158 Target#:77 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid